Trials / Conditions / Persistent Fetal Circulation Syndrome

Persistent Fetal Circulation Syndrome

9 registered clinical trials studyying Persistent Fetal Circulation Syndrome.

Status	Trial	Sponsor	Phase
Withdrawn	Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure NCT01891500	University of Florida	Phase 4
Unknown	Sildenofil in Persistent Pulmonary Hypertension in Newborns NCT01558466	Hamad Medical Corporation	Phase 3
Terminated	Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn NCT01088997	Children's Hospital of Philadelphia	N/A
Completed	Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO NCT00371241	The University of Texas Health Science Center, Houston	—
Terminated	Early Inhaled Nitric Oxide for Respiratory Failure in Newborns NCT00005773	NICHD Neonatal Research Network	Phase 3
Completed	Risk Factors for Pulmonary Hypertension of the Newborn NCT00005497	National Heart, Lung, and Blood Institute (NHLBI)	—
Terminated	Inhaled Nitric Oxide Study for Respiratory Failure in Newborns NCT00005776	NICHD Neonatal Research Network	Phase 3
Completed	Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study NCT01203423	NICHD Neonatal Research Network	—
Completed	Epidemiology of Persistent Pulmonary Hypertension of the Newborn - SCOR in Lung Biology and Diseases in Infant NCT00005323	National Heart, Lung, and Blood Institute (NHLBI)	—